Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Dynavax and Aventis Pasteur enter strategic collaboration to develop novel vaccines

Feb. 11, 2000

Immunomedics allowed patent for therapeutic vaccines

Feb. 10, 2000

FluMist provides unexpected protection against flu strain not covered by vaccine in children

Feb. 9, 2000

North American Vaccine reports Hib vaccine results to FDA advisory panel

Feb. 8, 2000

Development of Chlamydia vaccine subject of Argonex/Wyeth-Lederle collaboration

Feb. 7, 2000

Immunomodulating CB2 receptor ligands in development at Sanofi-Synthelabo

Feb. 7, 2000

Cel-Sci receives MIPS award to support TB vaccine development

Feb. 2, 2000

Nexell acquires access to Diaclone antibodies for use in cell therapy

Feb. 2, 2000

Application of Ariad's Dimerizer Drug technology covered by two U.S. patents

Jan. 31, 2000

Intranasal IL-12 is a potent adjuvant for enhancing antiviral immunity

Jan. 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.